China’s Practice of Anti-Suit Injunctions in SEP Litigation: Transplant or False Friend?
November 5, 2022
In 2020, China abruptly became the largest grantor of anti-suit injunctions (ASIs), which are court orders that prevent the opposing party from beginning or continuing a proceeding in another jurisdiction. China’s use of ASIs, which were used to address patent litigation initiated in a foreign country, was explicitly supported by